RECOMBINANT VECTORS DERIVED FROM ADENO-ASSOCIATED VIRUS EXPRESSING TAM67 FOR GENE THERAPY

Details for Australian Patent Application No. 2002325684 (hide)

Owner VRIJE UNIVERSITEIT BRUSSEL

Inventors TEUGELS, Erik; NEYNS, Bart; ZEINOUN, Ziad; VERMEIJ, Joanna; DE GREVE, Jacques

Pub. Number AU-A-2002325684

PCT Number PCT/BE02/00129

PCT Pub. Number WO2003/010321

Priority 01870166.4 26.07.01 EP

Filing date 26 July 2002

Wipo publication date 17 February 2003

International Classifications

C12N 015/86 Mutation or genetic engineering - Viral vectors

C12N 005/10 Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

A61K 048/00 Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 035/00 Antineoplastic agents

C07K 014/82 Peptides having more than 20 amino acids - Translation products from oncogenes

Event Publications

23 January 2003 Complete Application Filed

  Priority application(s): 01870166.4 26.07.01 EP

29 May 2003 Application Open to Public Inspection

  Published as AU-A-2002325684

8 April 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002325685-MOBILE DISTRIBUTION INSTALLATION FOR PRODUCTS

2002325683-RECOMBINANT VECTOR DERIVED FROM ADENO-ASSOCIATED VIRUS FOR GENE THERAPY